ENDOTEST A/S: Financial statements 2022
CVR: 34904790
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
ENDOTEST A/S (CVR 34904790) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 4,641,738 and a net result of DKK 1,468,853 compared with DKK 656,319 the year before. That is an increase of 48.7% compared with the year before. Equity in the 2022 report amounted to DKK 3,051,967. The solvency ratio was 57.5%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 4,641,738
- Profit/Loss
- DKK 1,468,853
- Equity
- DKK 3,051,967
- Total Assets
- DKK 5,305,371
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 4.6 mio. | 1.5 mio. | 3.1 mio. | 4 |
| 2021 | - | 3.1 mio. | 656 t. | 2.3 mio. | 3 |
| 2020 | - | 3.1 mio. | 826 t. | 2.4 mio. | 4 |
| 2019 | - | 3 mio. | 549 t. | 2.1 mio. | 4 |
| 2018 | - | 4.2 mio. | 805 t. | 2.1 mio. | - |
Official annual report
Keep an eye on ENDOTEST A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ENDOTEST A/S has published its annual report for 2021. Gross profit came to DKK 3,120,822, and the net result was DKK 656,319.
About ENDOTEST A/S
ENDOTEST A/S is a Danish company of the type Aktieselskab based in Roskilde, founded in 2013. The company is registered under the industry Agenturhandel med maskiner, teknisk udstyr, skibe og flyvemaskiner. The company was previously named ENDOTEST ApS. The management consists of Magnus Nordin Legarth Hilsøe. The board consists of Morten Hagemann Hilsøe (chair), Johan Nordin Hilsøe and Jørgen Hilsøe. The company is owned by HILAKE HOLDING ApS and NORHIL Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 8,036,854 and a net result of DKK 3,494,809 compared with DKK 3,068,408 the year before. Equity in the 2025 report amounted to DKK 6,291,465.